Correlation Between Enanta Pharmaceuticals and Elicio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Elicio Therapeutics, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Elicio Therapeutics.
Diversification Opportunities for Enanta Pharmaceuticals and Elicio Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Enanta and Elicio is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Elicio Therapeutics go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Elicio Therapeutics
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to generate 4.46 times less return on investment than Elicio Therapeutics. But when comparing it to its historical volatility, Enanta Pharmaceuticals is 2.02 times less risky than Elicio Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 589.00 in Elicio Therapeutics on August 27, 2024 and sell it today you would lose (96.00) from holding Elicio Therapeutics or give up 16.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enanta Pharmaceuticals vs. Elicio Therapeutics
Performance |
| Timeline |
| Enanta Pharmaceuticals |
| Elicio Therapeutics |
Enanta Pharmaceuticals and Elicio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enanta Pharmaceuticals and Elicio Therapeutics
The main advantage of trading using opposite Enanta Pharmaceuticals and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
| Elicio Therapeutics vs. Capricor Therapeutics | Elicio Therapeutics vs. Soleno Therapeutics | Elicio Therapeutics vs. Bio Path Holdings | Elicio Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |